BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23756958)

  • 21. Impact of prostate MRI image quality on diagnostic performance for clinically significant prostate cancer (csPCa).
    Cheng Y; Zhang L; Wu X; Zou Y; Niu Y; Wang L
    Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38935093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MR imaging of the prostate at 1.5-T without endorectal coil using an 8 channel pelvic phased array: Is it still a viable option?
    Pierro A; Di Marco M; Piacentini M; Astore C; Maselli G; Guerriero M; Di Lallo A; Sallustio G; Marcellino A; Cilla S
    Radiography (Lond); 2021 May; 27(2):459-463. PubMed ID: 33148474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.
    Lee CH; Vellayappan B; Tan CH
    Br J Radiol; 2022 Mar; 95(1131):20210509. PubMed ID: 34520694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-reader evaluation of different image quality scoring systems in prostate MRI.
    Hötker AM; Njoh S; Hofer LJ; Held U; Rupp NJ; Ghafoor S; Stocker D; Eberli D; Donati OF
    Eur J Radiol; 2023 Apr; 161():110733. PubMed ID: 36780738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
    Bao J; Zhi R; Hou Y; Zhang J; Wu CJ; Wang XM; Zhang YD
    J Magn Reson Imaging; 2021 Apr; 53(4):1210-1219. PubMed ID: 33075177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
    Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
    Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of multi-parametric magnetic resonance imaging through PIRADS scoring system in biopsy naïve patients with suspicious prostate cancer.
    Nowier A; Mazhar H; Salah R; Shabayek M
    Arab J Urol; 2022; 20(3):121-125. PubMed ID: 35935910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Prostate Imaging and Reporting Data System V2.0 and V2.1 for Evaluation of Transition Zone Lesions: A 5-Reader 202-Patient Analysis.
    Kim N; Kim S; Prabhu V; Shanbhogue K; Smereka P; Tong A; Anthopolos R; Taneja SS; Rosenkrantz AB
    J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):523-529. PubMed ID: 35405714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-Reader Variability Using PI-RADS v2 Versus PI-RADS v2.1: Most New Disagreement Stems from Scores 1 and 2.
    Beetz NL; Haas M; Baur A; Konietschke F; Roy A; Hamm CA; Rudolph MM; Shnayien S; Hamm B; Cash H; Asbach P; Penzkofer T
    Rofo; 2022 Aug; 194(8):852-861. PubMed ID: 35545106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone.
    Sun Z; Wang H; Fu W; Zhu S; Song G
    Abdom Radiol (NY); 2023 Jan; 48(1):390-398. PubMed ID: 36305943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of Dynamic Contrast-Enhanced (DCE) MR Imaging in Peripheral Lesions in PI-RADS-4 Patients.
    Ullrich T; Quentin M; Arsov C; Laqua N; Abrar D; Hiester A; Albers P; Antoch G; Schimmöller L
    Rofo; 2020 May; 192(5):441-447. PubMed ID: 31622990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers.
    Lee G; Chatterjee A; Harmath C; Karademir I; Engelmann R; Yousuf A; Islam S; Karczmar G; Oto A; Giurcanu M; Antic T; Eggener S
    Abdom Radiol (NY); 2023 Oct; 48(10):3216-3228. PubMed ID: 37358605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ancillary imaging and clinical features for the characterization of prostate lesions: A proposed approach to reduce false positives.
    Lee CM; Park KJ; Kim MH; Kim JK
    J Magn Reson Imaging; 2021 Jun; 53(6):1887-1897. PubMed ID: 33377264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of multiparametric MRI with histopathological grade of peripheral zone prostate carcinoma.
    Singla A; Deep N; Naik S; Mohakud S; Nayak P; Sable M
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S569-S576. PubMed ID: 38384020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI prostate PI-RAD scoring in a district general hospital: correlating PI-RADS 3 results with histological findings.
    Aslam S; Tsang J; Bickle I; Saiepour A
    Br J Radiol; 2022 Mar; 95(1131):20210804. PubMed ID: 34919444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between
    Liu Y; Dong Y; Liu J; Zhang X; Lin M; Xu B
    Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Negative Predictive Value of a PI-RADS Version 2 Score of 1 on Prostate MRI and the Factors Associated With a False-Negative MRI Study.
    Ma HY; Ahmed FS; Luk L; Martina LAP; Wenske S; Shaish H
    AJR Am J Roentgenol; 2020 Sep; 215(3):667-672. PubMed ID: 32755155
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
    Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
    Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
    Apfelbeck M; Pfitzinger P; Bischoff R; Rath L; Buchner A; Mumm JN; Schlenker B; Stief CG; Chaloupka M; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(4):503-511. PubMed ID: 33337358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.